Clinical Trials Logo

Clinical Trial Summary

Some rare cases of recurrent Campylobacter bacteraemia (RCB) exist with relapses months to years after an effective treatment and a negativation of all bacterial samples. As of today, only around 20 cases have been described in the international literature for the last 30 years. The cases are likely highly underreported. No study describes those recurrent Campylobacter bacteraemias at the scale of a country. The aim of this multicentre, nationwide, retrospective study is to describe their precise epidemiology in France for the last 25 years, the immune profile of the patients, the specificities of the bacteria involved, the treatments received and the evolution of these infections. The perspective is to propose a standardization of the medical care of those patients mainly by describing the effective treatments and the explorations of the immune system which should be considered.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06432777
Study type Observational
Source Hospices Civils de Lyon
Contact Anne CONRAD, Dr
Phone +33 (0)4 72 07 11 07
Email Anne.conrad@chu-lyon.fr
Status Not yet recruiting
Phase
Start date June 1, 2024
Completion date May 1, 2026

See also
  Status Clinical Trial Phase
Completed NCT03683667 - Protein Plus: Improving Infant Growth Through Diet and Enteric Health Phase 2/Phase 3
Completed NCT03266068 - Epidemiology and Pathophysiology of Post-Infectious Functional GI Disorders
Active, not recruiting NCT02040922 - Campylobacter Enteritis and Post-Infective Bowel Dysfunction (PI-BD): Role of Antibiotics and Microbiota N/A
Recruiting NCT01048112 - Campylobacter Jejuni Challenge Model Development: Assessment of Homologous Protection Phase 1
Recruiting NCT06425250 - Campylobacter Spp. Bone and Joint Infection: a Retrospective Cohort Study
Completed NCT04182490 - LMN-101 in a Campylobacter Human Challenge Model Phase 2
Active, not recruiting NCT00434798 - Campylobacter Jejuni Challenge Model Development: Dose Ranging Study Phase 1
Completed NCT02884752 - Retrospective Study of Bone Infection Due to Campylobacter Spp N/A